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Abstract: The /1-amyloid protein, the major component
of the vascular and plaque amyloid deposits that charac-
terize Alzheimer’s disease, derives from a larger /3-amy-
bid precursor protein (APP) that is expressed in both
neural and nonneural cells. An increased expression of
APP might actively contribute to the development of the
pathology; however, the mechanisms involved in the reg-
ulation of APP gene expression are not yet well under-
stood. In P012 cells, a rat pheochromocytoma cell line,
we have demonstrated that nerve growth factor (NGF)
induces the APP gene expression and increases APP
mRNA levels in the presence of 0.5 or 15% serum. Ex-
pression of activated ras in the PC12 cell subline UR61
also leads to a significant increase in content of APP
transcripts, and a dominant negative mutant of ras blocks
the NGF-induced response. Other ligands of tyrosine
kinase receptors, such as fibroblast growth factor,
which causes morphological differentiation, orepidermal
growth factor, which induces cell growth, also increase
APP mRNA levels in P012 cells. These results suggest
that ras mediates the induction of APP gene expression
by NGF and other ligands of tyrosine kinase receptors.
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Alzheimer’ s disease is a progressive and irreversible
disorder of the human CNS that is associated with
specific neuropathological lesions, including intracel-
lular neurofibrillary tangles and the progressive deposi-
tion of fibrillar aggregates of amyloid protein through-
out the brain. The major component of the amyloid
deposits, a hydrophobic 39—43-amino-acid peptide, is
proteolytically derived from a larger membrane pro-
tein, the /3-amyloid precursor protein (APP), which is
encoded by a gene located on human chromosome 21
(for a review, see Selkoe, 1994).
Because the APP gene plays a central role in Alzhei-
mer’s disease, an anomaly of its expression might con-
tribute to its development. The appearance of a pathol-
ogy similar to Alzheimer’s disease in Down’s syn-
drome, or trisomy 21, is correlated with increased
levels of APP mRNA, which result at least in part from
duplication of the APP gene (Neve et al., 1988). This
finding, as well as the degeneration of neurons overex-
pressing APP (Yoshikawa et al., 1992) or the appear-
ance of ~3-amyloid-immunoreactive deposits in trans-
genic mice carrying the human APP cDNA (Quon et
al., 1991; Games et al., 1995), strongly suggests that
overexpression of the APP gene is directly involved
in the formation of amyloid deposits and development
of Alzheimer’s disease.
APP is ubiquitously expressed in mammalian tis-
sues, with brain and kidney having the highest levels.
APP expression is induced in different cell types by
various cellular mediators, including nerve growth fac-
tor (NGF) (Mobley et al., 1988; Konig et al., 1990;
Ohyagi and Tabira, 1993), basic fibroblast growth fac-
tor (bFGF) (Quon et al., 1990), interleukin-1 (Gold-
gaber et al., 1989), retinoic acid (Konig et el., 1990),
or phorbol esters (Yoshikai et al., 1990; Trejo et al.,
1994).
NGF is one of the most well-characterized neuro-
trophic factors in vitro as well as in vivo (for a review,
see Levi-Montalcini, 1987), and the signal transduc-
tion pathways that mediate the cellular events induced
by this factor have been extensively studied. The ef-
fects induced by NGF and other growth factors such
as fibroblast growth factor (FGF) or epidermal growth
factor (EGF) are mediated by tyrosine kinase recep-
tors. On binding of the corresponding ligand the recep-
tors stimulate a cascade of intracellular signals that
control biochemical pathways leading to changes in
gene expression (for a review, see Schlessinger,
1993). PC12 cells, a rat pheochromocytoma cell line
(Greene and Tischler, 1976), have been useful in ana-
lyzing the molecular mechanisms of the actions of
NGF. Ligand activation of the NGF receptor leads to
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biochemical and morphological changes characteristic
of sympathetic neuronal differentiation, including neu-
rite extension, cessation of cell division, and expres-
sion of neuronal-specific genes (Halegoua et al.,
1991). FGF mimics many of the effects of NGF and
induces growth arrest and neurite extension (Togari et
al., 1983), whereas EGF promotes cell growth (Huff
et al., 1981; Rabin et al., 1993).
The products of the ras protooncogenes are small
proteins that bind guanine nucleotides, and there is
strong evidence that these proteins play an important
role in signal transduction from various receptors that
belong to the tyrosine kinase family of receptors. Ex-
pression of oncogenic mutant ras in PC12 cells results
in neuronal differentiation (Bar-Sagi and Feramisco,
1985; Guerrero et al., 1988), whereas microinjection
of anti-Ras antibodies reverses NGF-induced neurite
outgrowth (Hagag et a!., 1986; Kremer et al., 1991),
and a dominant inhibitory Ras mutant blocks morpho-
logical differentiation induced by NGF or FGF (Szeb-
erényi et al., 1990; Kremer et al., 1991). Furthermore,
these growth factors increase the amount of active
GTP-bound Ras (Muroya et al., 1992), and the pro-
tooncogene mediates the NGF modulation of differ-
ent signal-transducing protein kinases, including the
mitogen-activated protein kinase (MAPK) cascade
(Thomas et al., 1992; Wood et al., 1992).
NGF has beenfound to increase APP mRNA expres-
sion in SH-SY5Y human neuroblastoma cells (Konig
et al., 1990), in primary cultures prepared from mouse
whole brain (Ohyagi and Tabira, 1993), and in devel-
oping hamster brain (Mobley et al., 1988). By con-
trast, NGF does not influence the expression of APP
mRNA in the rat septal/nucleus basalis system (For-
loni et al., 1993). In PC12 cells, the APP is constitu-
tively expressed, and NGF has been reported to affect
differentially the expression of the distinct APP iso-
forms that are produced by alternative splicing of the
primary transcript (Fukuyama et al., 1993). Also, in
PC12 cells, NGF modulates the posttranslational pro-
cessing and induces the secretion of APP in cell culture
(Refolo et al., 1989). However, the mechanisms by
which NGF controls the expression of the APP gene
have not yet been examined.
In this work we have examined the possibility that
activation of Ras could play a role in the regulation of
APP gene expression by NGF and other ligands of the
tyrosine kinase receptors in PC12 cells. Our results
show that NGF induces an increase in APP mRNA
levels in PC12 cells. Expression of activated ras has
a similar effect, and a dominant negative mutant of
the ras protooncogene inhibits activation of APP gene
expression by NGF. These results strongly suggest that
NGF might increase APP mRNA levels in PC 12 cells
by a mechanism that involves the Ras pathway. EGF
and bFGF also activate Ras in PC12 cells (Qiu and
Green, 1992), and both factors are able to induce APP
gene transcripts in PC12 cells.
MATERIALS AND METHODS
Cell cultures
PC12 cells were cultured in RPMI medium containing
10% donor horse serum (Quality Biological) and 5% fetal
calf serum (GIBCO) in collagen-treated plates. The sub-
clones of PCI2 cells, UR6I and M-M17-26 cells, were
grown in a similar medium containing 10% horse serum and
5% fetal calf serum. UR61 cells were derived from PCI2
cells following transfection with a plasmid containing the
transformant mouse N-ras oncogene under the transcrip-
tional control of the dexamethasone-inducible mouse mam-
mary tumor virus promoter (Guerrero et al., 1988). The
PCI2 subline M-M17-26 was obtained by Szeberényi et a!.
(1990) after transfection with the dominant negative mutant
Ha-ras (Asn 17) gene transcribed from the promoter of the
mouse metallothionein-1 gene.This subclone constitutively
expresses high levels of mutant Ras protein that could not
be further induced by zinc.
The PCI2 subclones were incubated with the different
factors at the concentrations and for the times indicated in
the figures. The incubations were carried out either in high-
serum conditions (the medium indicated above) or in low-
serum conditions (medium containing 0.5% of a2:1 mixture
of donor horse serum/fetal calf serum). NGF and dexameth-
asone were obtained from Sigma, and bFGF and EGF were
obtained from Austral Biologicals.
RNA extraction and hybridization
Total RNA was extracted from the cell cultures with gua-
nidinium thiocyanate (Chomczynski and Sacchi, 1987). The
RNA was electrophoresed in 1% formaldehyde-agarose gels
and transferred to nylon-nitrocellulose membranes (Nytran)
for northern blot analysis. The RNA was stained with 0.02%
methylene blue. The blots were hybridized with a plasmid
containing a human APP cDNA labeled by random oligonu-
cleotide priming. Hybridizations were at 42°C with 50%
formamide, and the more stringent wash was at 42°Cwith
0.1 x saline—sodium citrate containing0.1% sodium dodecyl
sulfate. The mRNA levels were quantified by densitometric
scan of the autoradiograms. The values obtained were cor-
rected by the amount of RNA applied in each lane, which
was determined by densitometry of the stained membranes.
RESULTS
Effect of NGF on expression of the APP gene
Figure 1 illustrates a northernblot analysis with total
RNA obtained from PC 12 cells after different intervals
of treatment with NGF (50 ng/ml) in the presence of
0.5 or 15% serum. In both cases a unique band of APP
mRNA was observed in the range of 3.3 kb. Under
low-serum conditions a small increase in content of
APP mRNA is already observed after only 10 h of
treatment, and a maximal response (two- to threefold)
is observed at 48 h. In the presence of 15% serum
the response to NGF is more remarkable, reaching a
fivefold increase above the values found in the control
group. However, the response is delayed under these
conditions, and no differences are observed before 48
h of treatment. In the absence of NGF, APP mRNA
levels did not vary between 0 and 72 h in cells grown
with either 0.5 or 15% serum (data not shown).
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FIG. 1. Induction of APP mRNA by NGF in PC12 cells. Cells were incubated with 50 ng/mI of NGF in 0.5 (left) or 15% (right) serum.
At the indicated times cells were harvested, and 30 p.g of total RNA was processed for northern blot analysis as described in Materials
and Methods. Top panels: Quantification ofthese results. APP mRNA levels were determined by densitometric scan of autoradiograms
and corrected by the amount of RNAapplied. Data are expressed as fold induction above the levels found in control cells and represent
mean ±SD (bars) values of four determinations (duplicates from two separate assays). The 3.3-kb APP mRNA bands from the
autoradiogram and the 1 8S rRNA from the stained blots are illustrated in the middle and bottom panels, respectively. Control values
correspond to APP mRNA of cells harvested at 48 h in the experiments.
Implication of the ras protooncogene in regulation
of APP expression by NGF
Because various cellular responses to NGF are medi-
ated by the ras protooncogene products, we have ex-
amined the effect of activated Ras on APP gene expres-
sion in a PC12 cell subline (UR6I) that contains a
transfected ras oncogene under control of the inducible
MMTV promoter. Figure 2A shows the levels of APP
transcripts in these cells after different times of incuba-
tion with dexamethasone in the presence of 15% se-
rum. Incubation of UR61 cells with 100 nM dexameth-
asone leads to a two- to threefold increase in the levels
of APP mRNA that is observed as early as 3 h and is
maintained until 72 h. Presumably this induction is the
result of the previous induction of the ras transcript
that is detected after 1—2 h of treatment with dexa-
methasone (Guerrero et a!., 1988). However, to dis-
count adirect effect ofthe glucocorticoid on APP gene
we have also examined the effect of 100 n M dexameth-
asone on APP mRNA levels in PC12 cells. As shown
in Fig. 2B, dexamethasone does not elevate the levels
of APP transcripts in the parental cell line. These re-
sults demonstrate that in UR61 cells activated Ras is
responsible for the stimulation of APP gene expression
by the steroid. In these cells the induction of APP gene
expression by NGF was quantitatively similar to that
observed with Ras, increasing APP mRNA levels to
two- to 2.5-fold over control values between 8 and 48
h (data not shown).
To determine whether the endogenous Ras is re-
quired for stimulation of APP geneexpression by NGF,
we analyzed the ability of the growth factor to increase
levels of APP mRNA in PC12 (M-M17-26) cells,
which express a dominant negative Ras mutant. Figure
3 illustrates APP mRNA levels obtained in the ras
dominant negative cells after incubation with 50 ng/
ml of NGF for 8 and 48 h in the presence of either
0.5 (left panel) or 15% (right panel) serum. Under
both serum conditions the levels of the transcripts are
not stimulated by NGF in M-M17-26 cells. These re-
sults support the hypothesis that induction of APP gene
expression by NGF involves a signal transduction path-
way that requires the activity of Ras proteins.
Induction of APP mRNA by other ligands of
tyrosine kinase receptors
We have also analyzed the effect of other growth
factors such as FGF, EGF, insulin-like growth factor-
1, or platelet-derived growth factor on the expression
of the APP gene in PC12 cells. Figure 4 shows a north-
em blot analysis of RNA obtained from PC12 cells
treated for 16 h with 17 ng/ml of bFGF and 60 ng/ml
of EGF. A significant and similar increase (threefold
induction) of APP mRNA levels is observed with both
growth factors. A lower but detectable (1.5-fold induc-
tion) APP response is induced by 8 ng/ml of insulin-
like growth factor-I, whereas 10 ng/ml of platelet-
derived growth factor did not elicit any increase over
the control levels of APP mRNA (data not shown).
DISCUSSION
In this study we have examined the activation of the
APP gene in three variants of PCI2 cells: the parental
J. Neurochem., Vol. 67, No. 1, 1996
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FIG. 2. Regulation of APP mRNA levels by Ras. A: Autoradio-
gram (bottom panel) and densitometric determination of mRNA
levels of a representative northern blot carried out with 25 ~.tgof
RNAextracted from UR61 cells exposed to dexamethasone (100
nM) for the indicated times. APP mRNA bands from the autora-
diograms were quantified by scan densitometry and corrected
by the amount of RNA applied. The results, expressed as fold
induction over the control levels, are shown in the top panel.
Data are mean ±SD (bars) values. B: Autoradiogram corre-
sponding to a northern blot with RNAextracted from P012 cells
after 24 h of incubation in the absence (control) or the presence
of dexamethasone (Dex). In both cases 15% serum was present
in the culture medium.
FIG. 3. Effects of NGF on APP mRNA levels
in M-M17-26 cells, which express a dominant
negative Ras mutant. Total RNAwas extracted
after incubation with 50 ng/ml of NGF for the
indicated times, in the presence of either 0.5 or
15% serum. Northern blot analysis was carried
out with 25 jig of total RNA. Bands from the
autoradiogram and stained blots from the filter
membrane were quantified by densitometric
scanning. The APP mRNA levels, corrected by
the amount of rRNA applied and expressed as
relative units, are illustrated in the top panels.
Data are mean ±SD (bars) values.
cell line and two different subclones, one overex-
pressing the N-ras oncogene (UR61 cells) and the
other (M-M17-26 cells) containing a dominant inhibi-
tory mutant of ras. In agreement with results obtained
by other groups in different cell types (Mobley et al.,
1988; Konig et al., 1990; Ohyagi and Tabira, 1993),
we have observed that NGF induces APP gene expres-
sion in PC12 cells. In this cell line it has been also
described that NGF specifically increases levels of the
APP695 transcript and the release of this protein to the
medium (Refolo et al., 1989). In addition, it has been
shown that NGF differentially regulates the localiza-
tion of APP within these cells (Fukuyama et al., 1993).
Our results show that the NGF-mediated APP
mRNA response in PC12 cells is dependent on the
amount of serum present in the culture media. Under
low-serum conditions, a detectable increase in content
of APP transcripts is already observed after 10 h of
incubation with the growth factor, and the increase
reaches a two- to threefold induction after 24 h of
incubation. By contrast, in the presence of 15% serum
the response to NGF treatment is delayed, and no dif-
ferences are observed before 48 h. The increase is,
however, stronger than that observed under low-serum
conditions, reaching a four- to fivefold induction be-
tween48 and 72 h of treatment. The different induction
of APP mRNA observed in both cases suggests the
presence of still unidentified factors in the serum that
can regulate the transcription of the APP gene and
affect the NGF response.
Several second messenger pathways are activated in
response to NGF. However, no causal relationship has
been established between the activated second messen-
ger systems and many of the observed actions. An
increasing body of evidence suggests the involvement
of the ras gene product p21 in the NGF-triggered signal
J. Neurochem., Vol. 67, No. 1, 1996
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FIG. 4. Induction of APP mRNA by ligands of tyrosine kinase
receptors. APP mRNA levels were determined by northern blot
analysis in P012 cells after 16 h of incubation with or without
bFGF (17 ng/ml) or EGF (60 ng/ml) under low-serum conditions.
APP mRNA bands from the autoradiogram and 18S rRNA bands
from the filter membrane are shown in the middle and bottom
panels, respectively. Top panel: Densitometric quantification of
APP mRNA bands. Values are corrected by the corresponding
amount of rRNA and expressed as fold induction over control
levels. Data are mean ±SD (bars) values.
transduction pathway. To examine whether or not the
Ras system is involved in the regulation of APP ex-
pression, we have studied the induction of APP mRNA
by oncogenic Ras in the UR61 cell line. Treatment of
UR6 1 cells with dexamethasone results in a rapid and
sustained increase in content of APP transcripts. In
the UR61 subclone of PC12 cells, the transfected ras
protooncogene is under control of a dexamethasone-
inducible MMTV promoter. Because the glucocorti-
coid is unable to induce APP RNA in the parental
PC12 cells, it can be assumed that Ras is the signal
transduction pathway used by dexamethasone to in-
crease levels of APP transcripts in UR61 cells.
Evidence that activation of endogenous Ras could
play a crucial role in the signal transduction of NGF
that leads to APP gene expression comes from the
experiments with a PC12 subclone (M-M17-26) ex-
pressing the dominant inhibitory mutant Ras (Asn17)(Szeberényi et al., 1990). This mutant has a reduced
affinity for GTP, and inhibition of endogenous Ras
function by this mutant has been suggested to occur
through competition with normal Ras for regulatory
proteins that promote nucleotide exchange (Feig and
Cooper, 1988). Studies on the effects of Ras have
demonstrated that the Asn17 mutation is located in the
effector-binding motif, and therefore such a mutation
might disrupt the structure necessary for Ras to bind
to the effector proteins, such as c-Raf- 1 and phosphati-
dylinositol-3-hydroxy kinase, that are believed to be
responsible for transmitting the growth and differentia-
tion signals of growth factors (Warne et a!., 1993;
Rodriguez-Viciana et a!., 1994). Szeberényi et a!.
(1990) have shown that the mutant blocks the neurite
outgrowth induced by NGF of FGF, as well as the
induction of different genes.
The M-M17-26 cell line has been widely accepted
as a good model to investigate the role of Ras in NGF-
mediated signal transduction in PC12 cells, and it has
been useful to demonstrate that Ras proteins are in-
volved in PCI2 differentiation (Szeberényi et al.,
1990). Our results demonstrate that expression of the
dominant inhibitory mutant of Ras blocks the induction
of APP gene expression by NGF, thus suggesting the
requirement for a functional Ras signaling pathway
for this response. Possible damage of the enzymatic
machinery functioning downstream of ras has not been
excluded by our results in the M-M 17-26 Ras dominant
negative-containing cells. However, in these cells the
main Ras-dependent pathway has been described as
being functional, at least downstream of Raf (Tropp-
mair et al., 1992). Further studies are necessary to
clarify the specific role of Ras as well as the involve-
ment of effector proteins such as Raf or phosphatidyl-
inositol-3-hydroxy kinase in APP gene expression.
Different ligands of tyrosine kinase receptors have
neurotrophic or mitogenic effects in PC 12 cells, and
it has been also shown that growth factors can activate
Ras by increasing the level of Ras-GTP in these cells
(Qiu and Green, 1992). In this study we have shown
that FGF, which causes morphological differentiation,
and EGF, which promotes cell growth, induce a sig-
nificant increase in content of APP mRNA. Insulin-
like growth factor-i, another ligand of tyrosine kinase
receptors that activates ras, also induces this mRNA,
although with less potency. These results strongly sug-
gest that APP gene expression is regulated by NGF
and other ligands of tyrosine kinase receptors by a
mechanism that involves the previous activation of
Ras. In agreement with the absence of platelet-derived
growth factor receptors in PC12 cells (Heasly and
Johnson, 1992), this factor does not induce APP tran-
scripts in these cells.
The 5’ promoter region of the APP gene has been
cloned and characterized for both humans (Salbaum
et al., 1988; Lahiri and Robakis, 1991) and rodents
(Hoffman and Chernak, 1994), and it has been well
documented that it contains numerous regulatory re-
gions, including an AP- 1 site. It has been shown that
the phorbol ester-induced transcriptional activation of
the APP gene is mediated by a mechanism that in-
volves the activation of protein kinase C and expres-
sion of the transcription factor Jun/AP-1 (Trejo et al.,
1994). Because NGF, as well as FGF and EGF, in-
duces a Ras-dependent expression of this transcription
factor in PC12 cells (Greenberg et al., 1985), it is
possible that the AP-l element could be involved in
the regulation of the APP geneby these growth factors.
Evidence of a mutual relationship between the APP
and Ras-mediated actions of NGF is emerging. In
PC 12 cells, APP might be acting as a mediator of the
effects of NGF on neurite outgrowth (Milward et a!.,
1992), and a direct effect of the secreted forms of APP
on neunte extension has been recently described in
cortical neurons in culture (Al!inquant et al., 1995).
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The induction of neurite outgrowth by NGF is blocked
in the presence of antibodies directed against either
APP (Milward et al., i992) or Ras (Kremer et al.,
1991), showing that both proteins are involved in the
NGF-dependent induction of neurite outgrowth. In ad-
dition, it has been recently demonstrated that secreted
forms of APP activate the Ras-dependent MAPK cas-
cade in PC12 cells (Greenberg et al., 1994), which is
also well known to be activated by NGF by a Ras-
dependent mechanism (Thomas et al., 1992; Wood et
al., 1992).
Overexpression of the APP gene might be one of
the mechanisms that more directly contributes to the
developmentof Alzheimer’s disease. An increased ex-
pression of this gene might result in an aberrant pro-
cessing of the amyloid precursor, which leads tohigher
concentration of the amyloidogenic fragments that ap-
pear in the /3-amyloid deposits of the brain (Fucuchi
et al., 1992). Moreover, APP has been described as
activating the MAPK cascade, which enhances the
phosphorylation of the ~rprotein and promotes the for-
mation of paired helical filaments (Greenberg et al.,
1994). Therefore, overexpression of APP might also
contribute to the development of this pathology
through a mechanism that involves the formation of
intracellular tangles. The APP gene plays a central role
in Alzheimer’s disease, and because an anomaly of its
expression might contribute to the development of this
pathology, efforts shouldbe made to study the mecha-
nisms involved in APP expression. Knowledge about
the contribution of different growth factors to the con-
trol of APP gene expression would, it is hoped, help
us to clarify the molecular mechanisms implicated in
this pathology.
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